Gentamicin, Peak, Serum
Gentamicin is an aminoglycoside antibiotic used to treat life-threatening blood infections caused by gram-negative bacilli such as Citrobacter freundii, Acinetobacter species, Enterobacter species, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Providencia stuartii, Pseudomonas aeruginosa, and Serratia species. In addition, gentamicin is capable of inhibiting the growth of many gram-positive cocci, especially penicillinase-producing staphylococci.
The therapeutic levels of gentamicin should be measured at peak as well as trough concentrations. In patients with pre-existing renal damage or those to whom gentamicin has been administered for prolonged periods or in doses above the therapeutic range, hearing impairment and/or nephrotoxicity may develop. Therefore, monitoring of peak and trough gentamicin levels is critical in the prevention of these serious complications with the adjustment of dosage administration as indicated.
- Monitoring gentamicin therapy and its toxicity (adequacy of drug clearance)
Therapeutic: < 2.0 mcg/mL (trough), 5-8 mcg/mL (Gram pos peak), 8-10 mcg/mL (Gram neg peak)
Potentially Toxic: > 2.0 mcg/mL (trough), > 12 mcg/mL (peak)
Serum (Red top tube).
Stability
- Ambient: 72 hours
- Refrigerated: 7 days
- Antimicrob Agents Chemother (Bethesda). 1963;161:138-47. [PMID: 14274880]
- Am Fam Physician. 1998 Nov 15;58(8):1811-20. [PMID: 9835856]
- Clin Chem. 1998 May;44(5):1129-40. [PMID: 9590397]
- Crit Rev Biotechnol. 2008;28(3):173-212. [PMID: 18937107]
- Toxicol Rep. 2018 Nov 30;6:91-99. [PMID: 30581763]
- Br J Clin Pharmacol. 2001;52 Suppl 1:35S-43S. [PMID: 11564051]